Mikael Oscarson
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 31
- Pharmacogenetics and Drug Metabolism 30
-
- Eicosanoids and Hypertension Pharmacology 9
- Co-authors
- Magnus Ingelman‐SundbergRoman A. McLellanInger JohanssonMats HidestrandQun‐Ying YueFolke SjöqvistLeif BertilssonOlavi Pelkonen
In The Last Decade
Mikael Oscarson
44 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 2.3k
- Biochemistry 319
- Oncology 977
- Genetics 568
- Endocrinology, Diabetes and Metabolism 322
Countries citing papers authored by Mikael Oscarson
This map shows the geographic impact of Mikael Oscarson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Oscarson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Oscarson more than expected).
Fields of papers citing papers by Mikael Oscarson
This network shows the impact of papers produced by Mikael Oscarson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Oscarson. The network helps show where Mikael Oscarson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikael Oscarson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 2 | |
| 3 | 2010 | 20 | |
| 4 | 2008 | 33 | |
| 5 | 2007 | 22 | |
| 6 | 2006 | 106 | |
| 7 | 2005 | 36 | |
| 8 | 2004 | 26 | |
| 9 | 2004 | 46 | |
| 10 | 2003 | 52 | |
| 11 | 2002 | 13 | |
| 12 | 2002 | 110 | |
| 13 | 2001 | 128 | |
| 14 | 1999 | 383 | |
| 15 | 1999 | 76 | |
| 16 | 1999 | 182 | |
| 17 | 1999 | 152 | |
| 18 | 1997 | 169 | |
| 19 | 1997 | 98 | |
| 20 | 1994 | 370 |
About Mikael Oscarson
Mikael Oscarson is a scholar working on Pharmacology, Biochemistry, Clinical Biochemistry, Genetics and Computational Theory and Mathematics, having authored 47 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (30 papers), Drug Transport and Resistance Mechanisms (9 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Glutathione Transferases and Polymorphisms (8 papers), Computational Drug Discovery Methods (6 papers), Metabolism and Genetic Disorders (4 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Pharmacology (2.3k citations), Biochemistry (319 citations), Oncology (977 citations), Genetics (568 citations) and Endocrinology, Diabetes and Metabolism (322 citations). Mikael Oscarson has collaborated with scholars based in Sweden, Finland and Italy. Frequent co-authors include Magnus Ingelman‐Sundberg, Roman A. McLellan, Inger Johansson, Mats Hidestrand, Qun‐Ying Yue, Folke Sjöqvist, Leif Bertilsson, Olavi Pelkonen, David A. Evans and Charlotta Otter. Their work appears in journals such as Molecular Pharmacology, Biochemical and Biophysical Research Communications, FEBS Letters, Human Mutation and Ophthalmic Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.